Traws Pharma, Inc. (TRAW)

Pharmaceutical Preparations

Latest Price

$0.53

TTM P/E

Normalized P/E

Div Yield

Book Value

0.13

P/B Ratio

4.18

Valuation metrics

EPS: $0.82

Target P/E: 15×

Formula: EPS × P/E

P/E Fair Value

$12.30

+2207% upside

40.3% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
ORBIMED ADVISORS LLC	1.20M	$1.0M	7.88%	+597.7K	2026-06-30
Ally Bridge Group (NY) LLC	786.2K	--	5.15%	--	2026-06-30
ADAGE CAPITAL PARTNERS GP, L.L.C.	730.0K	--	4.78%	--	2026-06-30
ADAR1 Capital Management, LLC	597.7K	--	3.92%	+443.6K	2026-06-30
Lynx1 Capital Management LP	559.5K	--	3.67%	+544.4K	2026-06-30
Ikarian Capital, LLC	478.1K	--	3.13%	-200.0K	2026-06-30
SPHERA FUNDS MANAGEMENT LTD.	398.5K	--	2.61%	--	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	330.0K	--	2.16%	+274.9K	2026-06-30
JANE STREET GROUP, LLC	216.0K	--	1.42%	+194.8K	2026-06-30
Alyeska Investment Group, L.P.	164.4K	--	1.08%	+111.7K	2026-06-30